Forefront Wealth Management Inc. Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Forefront Wealth Management Inc. purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 547 shares of the biotechnology company’s stock, valued at approximately $325,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. Groupama Asset Managment acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA purchased a new stake in Axon Enterprise in the 3rd quarter valued at about $120,553,000. Proficio Capital Partners LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at about $78,414,000. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after buying an additional 111,405 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $560.00 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a fifty day moving average price of $591.90 and a 200 day moving average price of $540.96. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a market cap of $42.91 billion, a PE ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Needham & Company LLC restated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.